Skip to main content
OpenTrials

Clinical trial condition

B-cell Lymphoma

Explore clinical trials studying B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

83 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

B-cell Lymphoma trial results

Completed

A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

NCT03740529

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +35 more
Locations
  • Mayo Clinic of Scottsdale Scottsdale, Arizona, United States
  • Scripps Coastal Medical Center San Diego, California, United States
  • University of California San Francisco, Medical Center at Paranassus San Francisco, California, United States
  • Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States
View all 56 locations
View Trial Details
Completed

INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)

NCT03424122

Conditions
B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • University of Arizona Cancer Center - Out Pt. Tucson, Arizona, United States
  • Indiana Blood and Marrow Transplantation Indianapolis, Indiana, United States
  • Comprehensive Cancer Center of Nevada Las Vegas, Nevada, United States
  • Texas Oncology Austin, Texas, United States
View all 21 locations
View Trial Details
Completed

1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation

NCT03133221

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +34 more
Locations
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Completed

A Study of Glofitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP), or Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (CHP) in Participants With Non-Hodgkin Lymphomas or With DLBCL

NCT03467373

Conditions
B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Alabama Medical Center Birmingham, Alabama, United States
  • Levine Cancer Institute Charlotte, North Carolina, United States
  • Fox Chase-Temple Cancer Center Philadelphia, Pennsylvania, United States
  • Peter Maccallum Cancer Centre Melbourne, Victoria, Australia
View all 22 locations
View Trial Details
Completed

A Study to Investigate Zanubrutinib in Chinese Participants With B-cell Lymphoma

NCT03189524

Conditions
B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China
  • Jiangsu Province Hospital Nanjing, Jiangsu, China
  • Institute of Hematology and Hospital of Blood Disease Tianjin, Tianjin Municipality, China
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Participants With High-Risk Large B-Cell Lymphoma

NCT03761056

Conditions
B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Banner Health MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details
Completed

Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies

NCT03424603

Conditions
B Cells--Tumors, B-cell Lymphoma, Blood Protein Disorders, +26 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Oncology Associates, PC--HOPE Division Tucson, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
View all 22 locations
View Trial Details
Completed

Study of TG-1801 in Subjects With B-Cell Lymphoma

NCT03804996

Conditions
B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +12 more
Locations
  • TG Therapeutics Investigational Trial Site Heidelberg, Victoria, Australia
  • TG Therapeutics Investigational Trial Site Melbourne, Victoria, Australia
  • TG Therapeutics Investigational Trial Site Nedlands, Western Australia, Australia
View Trial Details

Related conditions